Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?

Cancer

Volumn 88, Issue 3, 2000, Pages 538-543

  Marsh, J Wallis ^a   Dvorchik, Igor ^a   Bonham, C Andrew ^a   Iwatsuki, Shunzaburo ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Outcomes analysis; Pathologic TNM classification

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHILD; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT PLANNING; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FORECASTING; HEPATECTOMY; HUMANS; LINEAR MODELS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TREATMENT OUTCOME;

EID: 0034141406     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000201)88:3<538::AID-CNCR7>3.0.CO;2-H     Document Type: Article

References (22)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. New Engl J Med 1999;340: 745-50.
2. Sobin LH, Wittekind CH. TNM classification of malignant tumours. 5th ed. New York: Wiley-Liss, Inc., 1997.
3. Izumi R, Shimizu K, Tohru II, Yagi M, Matsui O, Nonomura A, Miyazaki I. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 1994;106:720-7.
4. Asahara T, Dohi K, Katayama K, Itamoto T, Okamoto Y, Nakahara H, et al. Factors affecting postoperative prognosis in the solitary-nodule type of hepatocellular carcinoma: experience of 132 cases in our institute. Hiroshima J Med Sci 1998;47(3):99-104.
5. Olthoff KM. Surgical options for hepatocellular carcinoma: resection and transplantation. Liver Transplant Surg 1998; 4(5 Suppl 1):S98-104.
6. Lau H, Fan ST, Ng IO, Wong J. Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients. Cancer 1998;83(11):2302-11.
7. Paquet KJ, Gad HA, Lazar A, Koussouris P, Mercado MA, Heine WD, et al. Analysis of factors affecting outcome after hepatectomy of patients with liver cirrhosis and small hepatocellular carcinoma. Eur J Surg 1998;164(7):513-9.
8. Nagasue N. Liver resection for hepatocellular carcinoma: indications, techniques, complications, and prognostic factors. J Hepato-Biliary-Pancreat Surg 1998;5(1):7-13.
9. Regalia E, Fassati LR, Valente U, Pulvirenti A, Damilano I, Dardano G, et al. Pattern and management of recurrent hepatocellular carcinoma after liver transplantation, J Hepato-Biliary-Pancreat Surg. 1998;5(1):29-34.
10. Mise K, Tashiro S, Yogita S, Wada D, Harada M, Fukuda Y, et al. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis. Clin Cancer Res 1998;4(6):1475-82.
11. Taketomi A, Shimada M, Shirabe K, Kajiyama K, Gion T, Sugimachi K. Natural killer cell activity in patients with hepatocellular carcinoma: a new prognostic indicator after hepatectomy. Cancer 1998;83(1):58-63.
12. Llovet JM, Bruix J, Fuster J, Castells A, Garcia-Valdecasas JC, Grande L, et al. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology 1998;27(6):1572-7.
13. Peck-Radosavljevic M, Pidlich J, Bergmann M, Ferenci P, Seelos C, Wichlas M, et al. Preoperative TNM-classification is a better prognostic indicator for recurrence of hepatocellular carcinoma after liver transplantation than albumin mRNA in peripheral blood. Liver Transplant Oncology Group. J Hepatol 1998;28(3):497-503.
14. Naka T, Toyota N, Kaneko T, Kaibara N. Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma. Anticancer Res 1998;18(1B):555-64.
15. Otto G, Heuschen U, Hofmann WJ, Krumin G, Hinz U, Herfarth C. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis. Ann Surg 1998;227(3):424-32.
16. Honda K, Sbisa H, Tullo A, Papeo PA, Saccone C, Poole S, et al. p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation. Br J Cancer 1998;77(5):776-82.
17. Lise M, Bacchetti S, Da Pian P, Nitti D, Pilati PL, Pigato P. Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients. Cancer 1998;82(6):1028-36.
18. Shimada M, Takenaka K, Taguchi K, Fujiwara Y, Gion T, Kajiyama K, et al. Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 1998;227(1):80-5.
19. Chen NIF, Jeng LB. Partial hepatic resection for hepatocellular carcinoma. J Gastroenterol Hepatol 1997;12(9,10):S329-34.
20. Terris B, Laurent-Puig P, Belghitti J, Degott C, Henin D, Flejou JF. Prognostic influence of clinicopathologic features, DNA-ploidy, CD44H and p53 expression in a large series of resected hepatocellular carcinoma in France. Int J Cancer 1997;74(6):614-9.
21. Yokoyama I, Carr B, Saitsu H, Iwatsuki S, Starzl TE. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 1991;68(10):2095-100.
22. Marsh JW, Dvorchik I, Subotin M, Balan V, Rakela J, Popechitclev EP, Subbotin V, et al. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology 1997;26:444-50.